Four climate strategies that could reach across partisan divides
Coronavirus is no longer seen as high risk by many – and that’s undermining control measures
Pfizer, Moderna Results Leave Many Important Questions Unanswered
As Bill Ackman Shorts Credit, CDS Payouts Soar To Highest Level Since 2009
Fauci not advising Biden, sees no reason to quit Trump now: Reuters interview
Rise in antibiotics prescribed to dental patients in England during COVID-19 lockdown
Horos Asset Management 3Q20 Commentary
Why Buy Silver Now That Biden is President
The Global Economy Is Rolling Over As Lockdowns Return
NYC Mayor Warns Parents To Brace For Schools To Close Again Monday: Live Updates
Republicans Spark Sentiment Slump In Early November As 'Hope' Is Hammered
Charts of the Week: Voters by race; hazard pay for essential workers; slowing economic growth as coronavirus surges
Despite months of waiting you may not get coronavirus stimulus checks
Biden Team Downplays 'National Shutdown' Talk, NYC One Step Closer To Shutting Schools: Live Updates
US Open – US stocks rally on vaccine hopes and 2021 bets, PPI decelerates, Brexit, Oil slides, Gold surges
President-elect Biden's new COVID-19 task force gives the US a fresh chance to turn around a public health disaster
COVID-19 vaccine: how the 'mum test' can help ensure take-up
Futures Rebound As Markets Look Beyond Surge In Covid Cases
US Governors On Edge As Biden Team Downplays 'National Shutdown' Talk: Live Updates
NZD/USD rally takes pause
Euro yawns as GDP rebounds in Q3
Interferon beta-1a candidate for COPD advances to PhIII to test its potential against Covid-19
Hungary steps out of line with EU to order Russia’s COVID-19 vaccine
University of Exeter and Medicines Discovery Catapult in strategic partnership
Time to add some sunshine (vitamin D) to milk and bread
Doubling down on Sanofi's French roots, Paul Hudson infuses €50M into Jeito Capital to boost homegrown biotechs
"We Respect The Choice Of The American People" - China Among Last Major Nations To Recognize Biden Victory
Controversial US data firm Palantir could manage UK’s ailing Test and Trace scheme
Macro Briefing: 13 November 2020
Why lockdowns don't necessarily infringe on freedom